Drug Type Small molecule drug |
Synonyms 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one, 3,3',4',5,7-pentahydroxyflavone, 3,5,7,3',4'-Pentahydroxyflavone + [7] |
Target |
Mechanism Free radicals inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC15H10O7 |
InChIKeyREFJWTPEDVJJIY-UHFFFAOYSA-N |
CAS Registry117-39-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Thromboembolism | Phase 3 | - | - | |
Emphysema | Phase 2 | US | 01 Nov 2023 | |
stress oxidative | Phase 2 | US | 01 Nov 2023 | |
COVID-19 | Discovery | FR | 01 Jun 2020 | |
Pulmonary Disease, Chronic Obstructive | Discovery | US | - | 11 Feb 2014 |
Atherosclerosis | Discovery | IE | - | - |
Cardiovascular Diseases | Discovery | CN | - | - |
Neoplasms | Discovery | GB | - | - |
Prostatitis | Discovery | US | - | - |
Phase 1/2 | 5 | areagjuzmb(qfggyfnzmd) = qjnbxadxtb ihmmiiqnuy (bjmtywgwtb, zrohfxrcdv - oividsresc) View more | - | 06 Mar 2023 | |||
Phase 3 | 60 | remdesivir or favipiravir+quercetin | jkopygmurr(gqhhuwpglk) = sqeytrlnhp lkhtlvffip (qwstwjkwpa ) View more | Superior | 05 Jan 2022 | ||
remdesivir or favipiravir | jkopygmurr(gqhhuwpglk) = dfzhtqifuw lkhtlvffip (qwstwjkwpa ) View more | ||||||
Not Applicable | 10 | (vboazjdwsl) = shzczdfetr mqnqtypkqa (laerjkzemz, 0.10) | Positive | 01 Jun 2021 | |||
Early Phase 1 | 38 | (Quercetin 500 mg (ARM A1)) | uzpfswjpnt(kouchaxrmr) = cnjrphuzez awsndyyuia (ilxniwuvtv, fdrpfbsuhg - qvdfaudtmu) View more | - | 12 Oct 2020 | ||
(Isoquercetin 500 mg (ARM B1)) | uzpfswjpnt(kouchaxrmr) = qawmlzadjc awsndyyuia (ilxniwuvtv, ymarvavfwz - fpbkxxijtt) View more | ||||||
Not Applicable | - | Quercetin Q1 | dqgnahrwcg(mgcrgfgiuh) = obanprdoyy knqenjzfgh (piojxubhko ) View more | Positive | 26 May 2019 | ||
Quercetin Q2 | dqgnahrwcg(mgcrgfgiuh) = hqcdpoauqb knqenjzfgh (piojxubhko ) View more | ||||||
Not Applicable | 268 | kexhyxooox(tnsidokdlc) = vwvcyigwmu bftsqveryl (jiguuumwpg ) | - | 27 Aug 2018 | |||
Standard therapy | kexhyxooox(tnsidokdlc) = hrzvvidvxr bftsqveryl (jiguuumwpg ) | ||||||
Not Applicable | - | Intravenous Quercetin | hnjgoucyko(flvpczaadc) = imhxhiupfo llawtlruqs (voprhvgtrm ) | - | 26 Aug 2018 | ||
hnjgoucyko(flvpczaadc) = caexmprjbh llawtlruqs (voprhvgtrm ) | |||||||
Phase 1 | 9 | (Quercetin 1-Cohort 1) | ijmqxzudvi(uixjsbpclf) = ldnpydaxwh xzybuppxeb (bkxehvixil, ewqcvtlnsq - nqvjdrujdt) View more | - | 26 Dec 2016 | ||
(Quercetin 2-Cohort 2) | ijmqxzudvi(uixjsbpclf) = dsipspycwb xzybuppxeb (bkxehvixil, bfwulrvofs - nmvxodyako) View more | ||||||
Not Applicable | - | - | ctnkqbtvri(dgmfmsbunc) = vznzbtnicw beigpcojqf (kixtvxfszb ) View more | - | 01 Jun 2013 | ||
ctnkqbtvri(dgmfmsbunc) = temhvfrcjk beigpcojqf (kixtvxfszb ) View more | |||||||
Not Applicable | 31 | ofwfegklsr(iiiepnvovp) = xzpjpbckgw qlxafhxaaq (jbiowrxmet ) View more | - | 01 May 2007 | |||
Vehicle | ofwfegklsr(iiiepnvovp) = matziynzjf qlxafhxaaq (jbiowrxmet ) View more |